Our human health care (hhc) mission inspires us to discover and develop innovative solutions to help address unmet patient needs. Hear from Sarah Foster, Senior Director, Site of Care Marketing, on the crucial role hhc plays in improving patients' lives. #LifeAtEisai
卫材
制药业
Nutley,NJ 125,333 位关注者
Breaking through in the therapeutic areas of oncology and neurology. View our community guidelines: https://bit.ly/3dkY
关于我们
At Eisai Inc., human health care (hhc) is our goal. We give our first thought to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs. Eisai is a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases). Each group functions as an end-to-end global business with discovery, development, and marketing capabilities. Our U.S. headquarters, commercial and clinical development organizations are located in New Jersey; our discovery labs are in Massachusetts and Pennsylvania; and our global demand chain organization resides in Maryland and North Carolina. To learn more about Eisai Inc., please visit us at www.eisai.com/US. Comments and posts by users on this site are not created or controlled by Eisai Inc. and Eisai is not responsible for such content.
- 网站
-
https://us.eisai.com
卫材的外部链接
- 所属行业
- 制药业
- 规模
- 1,001-5,000 人
- 总部
- Nutley,NJ
- 类型
- 上市公司
- 创立
- 1995
- 领域
- Neurology、Gastroenterology、Alzheimer's disease、Oncology、Epilepsy、Insomnia、Metastatic breast cancer、renal cell carcinoma、hepatocellular carcinoma、dementia和endometrial cancer
地点
卫材员工
动态
-
Vijay Venugopal Iyengar MS, MBA, MPH, Senior Director, Sales and Marketing Strategic Solutions, brought #LifeAtEisai to the top of the world! Growing up in India, he dreamed of climbing Mt. Kailash. He made his dream a reality by spending two weeks in the Himalayas and trekking 18,500 feet total. At the top of the mountain, he placed the Eisai logo among hundreds of flags planted by those who came before him. Like Vijay, we’re dedicated to our hhc mission, no matter how steep the climb.
-
At Eisai, our focus is Science-Driven. Human-Centric. This means providing resources and community for people living with head and neck cancer (HNC) or thyroid cancer (TC), as well as for their loved ones and caregivers. In the coming months, we’ll have new stories, recipes and more about navigating mealtime and social gatherings: https://bit.ly/48anVV9 #MoreThanHNC #TruthAboutTC #headandneckcancer #thyroidcancer
-
Teamwork, strategy and fun in the sun! Our Ethics and Compliance team spent a day in Asbury Park, NJ, flexing their creative muscles as they designed sand sculptures and re-imagined their goals and strategies for 2025. Opportunities like this allow for our teams to build even stronger foundations while continuing on our promise to deliver on our goals with integrity. #LifeAtEisai
-
We’re thrilled to support the UMPS CARE Charities’ “Blue for Kids” program at Boston Children's Hospital. Two team members from our Cambridge office handed out Build-A-Bears, goody bags and notes of encouragement to help spread joy to young patients and their families. They also wrote notes of encouragement to make the event extra special. Thank you to everyone who makes these events possible! #LifeAtEisai
-
Ageism refers to stereotypes, prejudice and discrimination toward others or ourselves based on age. This #AgeismAwarenessDay, join our partner, the American Society on Aging, to #TalkAboutAgeism and reframe how we discuss aging and older adults in our communities. Learn how you can help #EndAgeism: https://bit.ly/3PKQcKf #LifeAtEisai
-
We are proud to share that Dr. Michael Irizarry, SVP and Deputy Chief Clinical Officer, has been named a 2024 PharmaVoice 100 Trailblazer!? This distinction honors industry leaders reshaping the pharma world. Dr. Irizarry has demonstrated this through his relentless commitment to addressing the unmet needs of people living with Alzheimer’s disease (AD) through innovative treatments that can help manage the earliest symptomatic stages of AD. Learn more here: https://bit.ly/4gZ7ChO
-
The Alzheimer's Foundation of America Educating America Tour connects communities across the country with information about #AlzheimersDisease, brain health, caregiving and more. We’re honored to sponsor such an impactful event where people can learn, make connections and hear stories from those who understand their experiences. Thank you for having us, AFA! #LifeAtEisai
-
Michael Irizarry, MD, MPH, Senior Vice President and Deputy Chief Clinical Officer of Eisai Neurology, had a conversation with Sharon Cohen, MD, FRCPC, and David Weisman, MD, about deriving clinical meaningfulness from Alzheimer’s disease (AD) clinical trials. View their discussion: https://bit.ly/3TSSUz7
-
We’re proud to support our local #AlzheimersDisease (AD) advocacy partners! Team Eisai walked with both Alzheimer's Foundation of America and Alzheimer's New Jersey to raise funds and support their missions to provide resources and education for those affected by AD and dementia. These events are a powerful testament to our community commitment to AD research and care. Walking alongside passionate individuals, care partners and families is inspiring and reaffirms our dedication to making strides toward a world without AD. #LifeAtEisai